From March 13th to 16th, 2025, CCDLM 2025, the annual event in the field of laboratory medicine and in vitro diagnostics in China, was grandly held in Chongqing. The theme of this conference is "Integrated Innovation, Intelligent Future", focusing on the deep integration of laboratory medicine and clinical needs, and promoting the further development of the "Big Laboratory" concept. As an important pillar of modern medical testing, the IVD (In Vitro Diagnosis) industry has undergone profound technological and applied changes in recent years. This conference not only showcased breakthroughs in cutting-edge fields such as molecular diagnostics and multi omics technology, but also delved into the broad prospects of IVD in healthcare, digital upgrading, and medical ecosystem integration.

Technology integration: AI empowerment and efficiency are equally important

From the industry signals conveyed at this conference, the future development trends of the IVD industry are mainly reflected in three aspects. Technological integration has become mainstream. The combination of traditional diagnostic technologies such as biochemistry, immunology, molecular testing, POCT (real-time testing), and artificial intelligence (AI) is significantly improving the accuracy and speed of detection. The introduction of AI technology not only optimizes the detection process, but also provides more reliable basis for clinical decision-making through big data analysis and machine learning.

Ecological closed-loop: from device sales to full chain services

Thirdly, IVD companies are gradually transitioning from a single equipment sales model to a full chain model of "detection diagnosis treatment". This ecological closed-loop model not only provides more comprehensive clinical solutions, but also enhances the market competitiveness of enterprises. For example, Mindray's "Qiyuan" critical illness model integrates multimodal data and can provide intelligent decision support for clinical doctors. Antu's Autolas X-1 intelligent assembly line combines automatic sorting technology to further optimize the laboratory's testing process and improve overall efficiency. This full chain service model not only improves the diagnosis and treatment level of medical institutions, but also provides better health management services for patients.

The AI Wave: Disruption and Restructuring of the IVD Industry

The rapid development of AI technology is profoundly changing the landscape of the IVD industry. The integration of AI+IVD technology not only accelerates the development of county-level medical and grassroots medical institutions, but also promotes the IVD industry to move towards a broader medical ecosystem. The future of the IVD industry is no longer limited to in vitro diagnostics, but is deeply integrated with industries such as ICT (Information and Communication Technology), biomedicine, and artificial intelligence, building a new medical technology ecosystem. CCDLM 2025 is not only an industry feast, but also a ticket to the future. Driven by digitalization, IVD enterprises are standing at the forefront of a new round of industrial upgrading. Only by using innovation as the spear and ecology as the shield can they break through the changing situation and emerge anew.

Desheng New Materials: Supporting Innovation and Upgrading in the IVD Industry

Behind the rapid development of the IVD industry, the support of high-quality raw materials is indispensable. As an important partner in the IVD industry, Desheng New Materials has always been committed to providing high-performance and high stability raw material solutions for IVD enterprises. Whether it is the core raw material of molecular diagnostic reagents or the key component of immune testing, Desheng New Materials helps IVD enterprises achieve technological breakthroughs and product upgrades with excellent quality and innovative technology.

Desheng New Materials is well aware that the future of the IVD industry lies in integration and innovation. Therefore, we have continuously increased our R&D investment and launched a series of products that are in line with industry development trends. For example, our enzyme preparations and antibody raw materials can significantly improve the sensitivity and specificity of detection reagents. Desheng New Materials not only focuses on product performance, but also emphasizes deep cooperation with customers, providing customized solutions to help IVD enterprises cope with market changes and technological challenges.